Related Experiment Video
Updated: Mar 26, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Non-coding RNA repertoires in malignant pleural mesothelioma
Leah Quinn1, Stephen P Finn2, Sinead Cuffe3
1Dept. of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; Dept. of Surgery, Trinity College Dublin, Ireland; MSc in Translational Oncology Program, Trinity College Dublin, Ireland.
Malignant pleural mesothelioma (MPM) is a rare cancer with few treatments. This review explores how non-coding RNAs (ncRNAs) contribute to MPM and their potential as diagnostic markers and therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer with limited therapeutic options.
- Current treatments for MPM are insufficient, highlighting the need for novel therapeutic strategies.
- Advances in understanding non-coding RNAs (ncRNAs) offer new avenues for cancer research.
Purpose of the Study:
- To review the role of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) in the pathogenesis of MPM.
- To explore the potential of ncRNAs as diagnostic biomarkers for MPM.
- To discuss the therapeutic potential of targeting ncRNAs in MPM treatment.
Main Methods:
- Literature review of recent research on ncRNAs in MPM.
- Analysis of the molecular mechanisms underlying MPM development.
- Evaluation of ncRNAs as potential biomarkers and therapeutic targets.
Main Results:
- ncRNAs, including lncRNAs and miRNAs, play significant roles in the development and progression of MPM.
- Specific ncRNAs have been identified as potential biomarkers for early detection and prognosis of MPM.
- Targeting ncRNAs presents a promising strategy for novel MPM therapies.
Conclusions:
- ncRNAs are crucial in MPM pathogenesis and represent promising biomarkers.
- Targeting ncRNAs offers a potential new therapeutic avenue for malignant pleural mesothelioma.
- Further research into ncRNAs could significantly improve MPM patient outcomes.
More Related Videos
11:11Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
Abnormal Proliferation
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Non-LTR Retrotransposons
The Nucleolus